Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
Franco P, Montagnani F, Arcadipane F, Casadei C, Andrikou K, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Cascinu S, Ricardi U, Casadei Gardini A. Franco P, et al. Among authors: casadei c, casadei gardini a. Radiat Oncol. 2018 May 2;13(1):83. doi: 10.1186/s13014-018-1035-9. Radiat Oncol. 2018. PMID: 29720197 Free PMC article.
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).
Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell'Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P. Casadei-Gardini A, et al. Among authors: casadei c. Cancer Manag Res. 2019 Apr 26;11:3631-3642. doi: 10.2147/CMAR.S197349. eCollection 2019. Cancer Manag Res. 2019. PMID: 31118786 Free PMC article.
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum].
Casadei-Gardini A, Montagnani F, Casadei C. Casadei-Gardini A, et al. Among authors: casadei c. Cancer Manag Res. 2019 Jun 25;11:5123. doi: 10.2147/CMAR.S215110. eCollection 2019. Cancer Manag Res. 2019. PMID: 31417303 Free PMC article. No abstract available.
CAR-T cell therapy: a potential new strategy against prostate cancer.
Schepisi G, Cursano MC, Casadei C, Menna C, Altavilla A, Lolli C, Cerchione C, Paganelli G, Santini D, Tonini G, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: casadei c. J Immunother Cancer. 2019 Oct 16;7(1):258. doi: 10.1186/s40425-019-0741-7. J Immunother Cancer. 2019. PMID: 31619289 Free PMC article. Review.
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors.
Schepisi G, Brighi N, Cursano MC, Gurioli G, Ravaglia G, Altavilla A, Burgio SL, Testoni S, Menna C, Farolfi A, Casadei C, Tonini G, Santini D, De Giorgi U. Schepisi G, et al. Among authors: casadei c. J Oncol. 2019 Sep 19;2019:7317964. doi: 10.1155/2019/7317964. eCollection 2019. J Oncol. 2019. PMID: 31641355 Free PMC article. Review.
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors.
Schepisi G, Conteduca V, Casadei C, Gurioli G, Rossi L, Gallà V, Cursano MC, Brighi N, Lolli C, Menna C, Farolfi A, Burgio SL, Altavilla A, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: casadei c. Front Oncol. 2020 Sep 23;10:565857. doi: 10.3389/fonc.2020.565857. eCollection 2020. Front Oncol. 2020. PMID: 33072597 Free PMC article. Review.
113 results